IN8bio (INAB) Competitor Comparison
We are evaluating the key criteria listed to compare IN8bio (INAB) against its competitors in the Biotechnology industry.
Market Capitalization
0 / 377Gross Profits
0 / 285Total Revenue
0 / 309EBITDA
0 / 345Free Cashflow
0 / 361Quick Ratio
0 / 366Earnings per Share
0 / 367Dividend yield
0 / 5Total Cash
0 / 367Performance 3 years
0 / 377Performance 5 years
0 / 377Performance 10 years
0 / 377Linearity 3 years
0 / 377Linearity 5 years
0 / 377Linearity 10 years
0 / 377Total Rank
0 / 377Dividend Rank
0 / 377Valuation Rank
0 / 377Piotroski Rank
0 / 377Muliplier Rank
0 / 377Market Capitalization - INAB ranking 0 / 377
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.